The COVID-19 pandemic had impacted the world in ways that were unthinkable just a few years ago. As the virus swept across the globe, there was an urgent need for diagnostic testing, particularly for the detection of the SARS-CoV-2 virus that causes COVID-19. Sansure, a Chinese biotechnology company, has emerged as a leading COVID-19 test kit supplier, providing high-quality testing solutions to healthcare providers around the world.
Introduction to Sansure Biotech
Sansure Biotech was founded in 2008 and is headquartered in Changsha, China. The company specializes in the research, development, and production of molecular diagnostic products, including COVID-19 test kits. The company has established partnerships with numerous hospitals, universities, and research institutions around the world.
Development of COVID-19 test kits by Sansure Biotech
Sansure Biotech was one of the first companies to develop a COVID-19 test kit. The company’s COVID-19 nucleic acid detection kit uses real-time fluorescence RT-PCR technology to detect the presence of the SARS-CoV-2 virus in human samples. The test kit has high sensitivity and specificity.
Global distribution and impact of Sansure Biotech’s COVID-19 test kits
Since the outbreak of the COVID-19 pandemic, Sansure Biotech has supplied its COVID-19 test kits to healthcare providers in over 100 countries and regions around the world. The company has worked tirelessly to increase its production capacity to meet the growing demand for COVID-19 testing.
In conclusion, Sansure Biotech has played a vital role in providing high-quality COVID-19 test kits to healthcare providers worldwide. Through its research and development efforts, global distribution, and collaborations with leading institutions, Sansure Biotech has significantly impacted the fight against the COVID-19 pandemic. The company’s commitment to providing accurate and reliable testing solutions has been instrumental in controlling the spread of the virus.